These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7322455)

  • 21. Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor.
    Pratt JA; Stolerman IP; Garcha HS; Giardini V; Feyerabend C
    Psychopharmacology (Berl); 1983; 81(1):54-60. PubMed ID: 6415731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that nicotine can acutely desensitize central nicotinic acetylcholinergic receptors.
    James JR; Villanueva HF; Johnson JH; Arezo S; Rosecrans JA
    Psychopharmacology (Berl); 1994 Apr; 114(3):456-62. PubMed ID: 7855204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholinergic drugs regulate passive avoidance performance via the amygdala.
    Riekkinen P; Riekkinen M; Sirviö J
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1484-92. PubMed ID: 8263810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicotine-induced tolerance and dependence in rats and mice: studies involving schedule-controlled behavior.
    Rosecrans JA; Stimler CA; Hendry JS; Meltzer LT
    Prog Brain Res; 1989; 79():239-48. PubMed ID: 2587745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat.
    Smith JW; Mogg A; Tafi E; Peacey E; Pullar IA; Szekeres P; Tricklebank M
    Psychopharmacology (Berl); 2007 Feb; 190(2):157-70. PubMed ID: 17115136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rats exhibiting acute behavioural tolerance to nicotine have more [125I]alpha-bungarotoxin binding sites in brain than rats not exhibiting tolerance.
    Zhang X; Paterson D; James R; Gong ZH; Liu C; Rosecrans J; Nordberg A
    Behav Brain Res; 2000 Aug; 113(1-2):105-15. PubMed ID: 10942037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (-)-Nornicotine partially substitutes for (+)-amphetamine in a drug discrimination paradigm in rats.
    Bardo MT; Bevins RA; Klebaur JE; Crooks PA; Dwoskin LP
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1083-7. PubMed ID: 9408217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of nicotinic receptor alpha 7 subunits in nicotine discrimination.
    Stolerman IP; Chamberlain S; Bizarro L; Fernandes C; Schalkwyk L
    Neuropharmacology; 2004 Mar; 46(3):363-71. PubMed ID: 14975691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lead-induced changes in muscarinic cholinergic sensitivity.
    Cory-Slechta DA; Pokora MJ
    Neurotoxicology; 1995; 16(2):337-47. PubMed ID: 7566693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for a noncholinergic site for nicotine's action in brain: psychopharmacological, electrophysiological and receptor binding studies.
    Abood LG; Lowy K; Tometsko A; MacNeil M
    Arch Int Pharmacodyn Ther; 1979 Feb; 237(2):213-29. PubMed ID: 485689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arecoline induced nicotinic and muscarinic stimulation of the superior cervical ganglion of cat.
    Tripathi ON
    Biomed Biochim Acta; 1983; 42(2-3):275-82. PubMed ID: 6882412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discriminative stimulus properties of physostigmine in rats.
    Tang AH; Franklin SR
    Eur J Pharmacol; 1988 Aug; 153(1):97-104. PubMed ID: 3215280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors.
    Tucci SA; Genn RF; File SE
    Neuropharmacology; 2003 Mar; 44(3):367-73. PubMed ID: 12604094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of dopamine release from neuron-enriched tissue cultures by cholinergic agents.
    Barochovsky O; Bradford HF
    J Neurochem; 1987 Mar; 48(3):798-803. PubMed ID: 3806105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: effects on spatial working memory in rats.
    Kim JS; Levin ED
    Brain Res; 1996 Jul; 725(2):231-40. PubMed ID: 8836529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor.
    Hernandez CM; Terry AV
    Neuroscience; 2005; 130(4):997-1012. PubMed ID: 15652996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discriminative stimulus properties of muscarinic agonists.
    Jung M; Costa L; Shearman GT; Kelly PH
    Psychopharmacology (Berl); 1987; 93(2):139-45. PubMed ID: 3122245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats.
    Zakharova ES; Danysz W; Bespalov AY
    Psychopharmacology (Berl); 2005 Apr; 179(1):128-35. PubMed ID: 15682308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine.
    Gasior M; Shoaib M; Yasar S; Jaszyna M; Goldberg SR
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1053-73. PubMed ID: 10027843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sites, mechanisms, and structural characteristics of the brain's nicotine receptor.
    Abood LG; Banerjee S; Kanne DB
    J Subst Abuse; 1989; 1(3):259-71. PubMed ID: 7580218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.